LONDON (Alliance News) - GlaxoSmithKline PLC and Theravance Inc Monday launched their chronic obstructive pulmonary disease treatment Anoro Ellipta at retail pharmacies in the US. Under the terms of its agreement with Glaxo, Theravance has agreed to make a milestone payment of USD30 million Read More
LONDON (Alliance News) -<strong> AstraZeneca</strong> has led the FTSE 100 all Monday morning after US drugs giant Pfizer confirmed that it has now twice approached British peer with a takeover proposal.<br /><br />Pzifer said it is considering its options after being rebuffed for a second tim Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>AstraZeneca</strong>, up 15%. US drugs giant Pfizer Inc has confirmed that it has now t Read More
LONDON (Alliance News) - UK stocks indices are mixed Monday, with little in the economic calendar to provide direction and developments in Ukraine weighing on sentiment, but with a significant shot-in-the-arm provided by continued merger and and acquisition activity in the pharmaceutical sector.< Read More
LONDON (Alliance News) - Lombard Medical Technology PLC Friday announced it has suspended trading on AIM, after it raised USD55 million in its initial public offering on the NASDAQ market in New York. The company's shares will be cancelled from the AIM market next Wednesday, when it will b Read More
LONDON (Alliance News) - Botox maker Allergan Inc approached Ireland-based pharmaceutical firm Shire PLC about a possible takeover in recent months, but was rebuffed, Reuters reported late Thursday citing people familiar with the matter. The approach did not progress to serious discussions Read More
LONDON (Alliance News) - <strong>AstraZeneca</strong> shares jumped Thursday after the pharmaceutical giant maintained its full-year guidance for 2014, even as its pretax profit dropped in the first quarter to end-March, hit by write-downs on the sale of its Alderley Park site and its acquisit Read More
LONDON (Alliance News) - Stocks drifted lower across the UK and Europe Wednesday following the release of sluggish Chinese economic data. <br /><br />Despite some positive UK and European economic news, as well as some stand-out UK stock movers, equity indices are broadly lower as investors aw Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Associated British Foods</strong>, up 8.9%. The food, ingredients and retail group r Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE RAISES WOLSELEY TO 'OUTPERFORM' ('NEUTRAL') - TARGET 4000 (3400) PENCE <br />----------<br />TRADERS: CREDIT SU Read More
LONDON (Alliance News) - UK shares are flat to higher Wednesday following a firm close in the US. <br /><br />Several UK blue-chips and mid-caps - including <strong>Reed Elsevier</strong>, <strong>ARM Holdings</strong> and <strong>MoneySupermarket.com</strong> - sought to provide reassurance a Read More
LONDON (Alliance News) - UK equities closed mixed Tuesday, with large- and mid-cap stocks outperforming their smaller peers to end the day in positive territory for the third trading day in a row, as individual company news took centre stage.<br /><br />Following a four-day Easter break, Londo Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that, along with Theravance Inc, it will be launching a phase III study for the combination treatment of fluticasone furoate/vilanterol for chronic obstructive pulmonary disease. Glaxo said that positive results from the study would Read More
LONDON (Alliance News) - Pharmaceutical stocks are reigning over the first session following the long Easter bank holiday, with mergers and acquisitions leading investor interest.<br /><br /><strong>GlaxoSmithKline</strong> has signed a three-part inter-conditional transaction with Swiss healt Read More